The International Journal of Neuropsychopharmacology
-
Publication Venue For
- Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care.. 18:pyu100. 2014
- Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.. 16:301-311. 2013
- Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.. 12:23-31. 2009
- Potential role of pregabalin in the treatment of lithium-induced tremor: a case report.. 11:879-881. 2008
- Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice.. 11:547-552. 2008
- rTMS strategies for the study and treatment of schizophrenia: a review.. 11:563-576. 2008
- Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.. 11:63-70. 2008
- Durability of antidepressant response to vagus nerve stimulation (VNS).. 10:817-826. 2007
- Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS).. 9:1-11. 2006
- Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).. 9:95-100. 2006
- Sleep microarchitecture as a predictor of recurrence in children and adolescents with depression.. 5:217-228. 2002
- Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.. 5:73-103. 2002
- Social anxiety disorder in review: two decades of progress.. 4:279-298. 2001
- Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder.. 4:159-168. 2001
- Efficacy and safety of lisdexamfetamine dimesylate in adults with executive dysfunction and partial or full remission of major depressive disorder 2012
- Development of adaptive treatment strategies in mood disorders: Rethinking maintenance therapy trials 2010
- Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder 2008
- Metabolomic mapping of schizophrenic patients treated with atypical antipsychotics discloses drug-specific differences in global lipid changes 2008
- A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with OROS methylphenidate in Treatment Resistant Depression 2006
- Developing nicotinic therapy for cognitive impairment of schizophrenia and aging-related dementia 2006
- Measures of cognitive change in schizophrenia clinical trials 2006
- Nicotine-antipsychotic drugs interaction and sustained attention in rats 2006
- The medical burden of depression 2006
- White matter hyperintensity progression and late-life depression outcomes 2006
- Can the panss cognitive factor be a valid surrogate for neurocognition in schizophrenia? 2004
- Cognition as a key to alliance, adherence, and functional outcomes 2004
- Is cognitive improvement with antipsychotic treatment pseudospecific? 2004
- Medical comorbidity: Special patient populations 2004
- Treatment of cognitive deficits in first episode schizophrenia 2004